Literature DB >> 1802470

[A case of HTLV-1 associated myelopathy and adult T-cell leukemia, presenting unique muscle pathology including rimmed vacuole].

S Honma1, K Yamada, F Moriwaka, K Shima, K Tashiro.   

Abstract

A 63-year-old man developed muscular atrophy and weakness in his four extremities since 1983, and was pointed out to have smoldering ATL by elevated HTLV-1 antibody titers in the serum (x 2,500) and CSF (x 32) in 1985. Neurological examinations revealed proximal muscular weakness and atrophy of four extremities, and mild spasticity of both legs. Deep tendon reflexes were hypoactive in both arms and hyperactive in both lower extremities with ankle clonus and bilateral positive Babinski and Chaddock reflexes. These findings were compatible with HAM. His gait, however, was markedly waddling, requiring support. Muscle biopsy at left biceps muscle revealed inflammatory change with rimmed vacuoles, small group atrophy, and marked type 1 fiber predominance. These findings on muscle biopsy are different from those of previously reported cases with HAM, showing some similarities to inclusion body myositis or distal myopathy with rimmed vacuole.

Entities:  

Mesh:

Year:  1991        PMID: 1802470

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Eiji Matsuura; Akiko Yoshimura; Satoshi Nozuma; Itsuro Higuchi; Ryuji Kubota; Hiroshi Takashima
Journal:  BMC Neurol       Date:  2015-02-28       Impact factor: 2.474

2.  Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Yosuke Nakaya; Masahiro Yoshida; Minako Tsutsumi; Hoyuri Fuseya; Mirei Horiuchi; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Ki-Ryang Koh; Daisuke Niino; Takeshi Inoue; Takahisa Yamane
Journal:  J Clin Exp Hematop       Date:  2019-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.